DORIBAX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Doribax, and when can generic versions of Doribax launch?
Doribax is a drug marketed by Shionogi Inc and is included in one NDA.
The generic ingredient in DORIBAX is doripenem. There are five drug master file entries for this compound. Additional details are available on the doripenem profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DORIBAX?
- What are the global sales for DORIBAX?
- What is Average Wholesale Price for DORIBAX?
Summary for DORIBAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 69 |
Clinical Trials: | 3 |
Patent Applications: | 4,541 |
Drug Prices: | Drug price information for DORIBAX |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for DORIBAX |
DailyMed Link: | DORIBAX at DailyMed |
Recent Clinical Trials for DORIBAX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Janssen Pharmaceutica | |
Pulmonary Associates, PA | Phase 1 |
Janssen-Cilag Ltd.,Thailand | Phase 4 |
US Patents and Regulatory Information for DORIBAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shionogi Inc | DORIBAX | doripenem | INJECTABLE;INTRAVENOUS | 022106-002 | Oct 5, 2010 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Shionogi Inc | DORIBAX | doripenem | INJECTABLE;INTRAVENOUS | 022106-001 | Oct 12, 2007 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DORIBAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Shionogi Inc | DORIBAX | doripenem | INJECTABLE;INTRAVENOUS | 022106-002 | Oct 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Shionogi Inc | DORIBAX | doripenem | INJECTABLE;INTRAVENOUS | 022106-001 | Oct 12, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Shionogi Inc | DORIBAX | doripenem | INJECTABLE;INTRAVENOUS | 022106-001 | Oct 12, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Shionogi Inc | DORIBAX | doripenem | INJECTABLE;INTRAVENOUS | 022106-002 | Oct 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for DORIBAX
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Janssen-Cilag International NV | Doribax | doripenem | EMEA/H/C/000891 Doribax is indicated for the treatment of the following infections in adults:nosocomial pneumonia (including ventilator-associated pneumonia);complicated intra-abdominal infections;complicated urinary tract infections.Consideration should be given to official guidance on the appropriate use of antibacterial agents. |
Withdrawn | no | no | no | 2008-07-25 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for DORIBAX
See the table below for patents covering DORIBAX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 1052474 | ⤷ Sign Up | |
Taiwan | 224967 | ⤷ Sign Up | |
Luxembourg | 91519 | ⤷ Sign Up | |
World Intellectual Property Organization (WIPO) | 0172750 | ⤷ Sign Up | |
Austria | 304014 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for DORIBAX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0528678 | 09C0005 | France | ⤷ Sign Up | PRODUCT NAME: DORIPENEME; REGISTRATION NO/DATE IN FRANCE: EU/1/07/467/001 DU 20080725; REGISTRATION NO/DATE AT EEC: EU/1/08/467/001 DU 20080725 |
0528678 | CR 2009 00003 | Denmark | ⤷ Sign Up | PRODUCT NAME: DORIPENEM, HERUNDER DORIPENEMMONOHYDRAT; REG. NO/DATE: EU/1/08/467/001 20080725 |
0528678 | C00528678/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: DORIPENEMUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 58667 19.10.2009 |
0528678 | 91519 | Luxembourg | ⤷ Sign Up | 91519, EXPIRES: 20170818 |
1270575 | 333 | Finland | ⤷ Sign Up | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |